CONFIRMED: The maker of EpiPen overcharged the government, and lawmakers are furious
The FDA just approved another new drug that could save the US billions — but there's a catch
Pfizer Shrinks Its Drug Pipeline Amid R&D Cuts
The Problem with Fast-Tracking Drug Approvals: Pharmas Fail to Follow Up
Which Sector Lost the Most Jobs in 2010? Pharma
AstraZeneca's Brilinta Fails to Win FDA Approval
WikiLeaks: Did Pfizer Use Unethical Tactics to Evade a Clinical Trial Settlement?
Johnson & Johnson Launches Offer for Crucell
FDA Panel Backs Orexigen's Diet Pill
Novartis Halts Lung Cancer Drug Study
Sanofi-Aventis to Cut 1,700 Jobs in the U.S.
Legal Briefing: IRS and Justice Department Target More Rich Tax Cheats
InterMune Shares Soar After FDA Panel Backs Lung Disease Drug
Why American Industry Could Become Dangerous
Genzyme's bad year gets worse: Experimental kidney drug a no-go
Amgen's troubles keep compounding; Aranesp studies reveal greater risks
Heartburn drug illuminates growing mistrust of pharmaceuticals
Sanofi-Aventis buys Merck's stake in Merial for $4 billion
Big dosage, big profit: Does Genzyme encourage larger dosages than we need?
Will Wal-Mart make drug retailers sick?
Merck merges with Schering-Plough in yet another Big Pharma mega-deal
Get help paying for your prescription medications